Previous 10 | Next 10 |
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an option to purchase 15,000 shares of common stock and (ii) 7,500 restricted stock units. The ...
WALTHAM, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Nancy Griffith, Ph.D., as vice president, scientific communications and medical operations, reporting to Brian Robinson, M.D., senior vice president,...
WALTHAM, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical development, medical and regulatory affairs for Novo Nordisk, Inc...
During the 1992 presidential campaign, candidate Bill Clinton used the slogan “It’s the economy stupid” in the race with opponent George H.W. Bush. Due to a short recession during the time frame, the slogan proved to be prophetic to the final outcome of the election, with ...
WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Ted Myles, chief financial officer, will present at the Needham 18 th Annual Healthcare Conference in New York City on Tuesday, April 9, 2019 at 4:10 p.m. A live audio webcas...
ARLINGTON, Va. and WALTHAM, Mass., March 20, 2019 (GLOBE NEWSWIRE) -- March of Dimes and AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced Baystate Medical Center’s Wesson Women’s Clinic in Springfield, Mass. as the first Supportive Pregnancy Care (SPC) site, supported ...
Gainers: TrovaGene (NASDAQ: TROV ) +74% . Stellar Biotechnologies (NASDAQ: SBOT ) +51% . Tenax Therapeutics (NASDAQ: TENX ) +51% . Globus Maritime (NASDAQ: GLBS ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +36% . Tonix Pharmaceuticals Holding (NASDAQ: TNXP ) +28% . Pulmatrix (N...
AMAG Pharmaceuticals (NASDAQ: AMAG ) is down 6% premarket on light volume in response to disappointing results from a Phase 3 clinical trial, PROLONG , evaluating Makena (hydroxyprogesterone caproate injection) for the prevention of preterm birth in women with histories of pri...
WALTHAM, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today topline results from PROLONG (Progestin’s Role in Optimizing Neonatal Gestation), a randomized, double-blinded, placebo-controlled clinical trial evaluating Makena® i...
WALTHAM, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that new and encore data related to bremelanotide and Hypoactive Sexual Desire Disorder (HSDD) will be presented at the upcoming International Society for the Study of Women's Sexual ...
News, Short Squeeze, Breakout and More Instantly...
AMAG Pharmaceuticals Inc. Company Name:
AMAG Stock Symbol:
NASDAQ Market:
AMAG Pharmaceuticals Inc. Website:
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...